Skip to main content
. 2020 Jul 15;17(14):5120. doi: 10.3390/ijerph17145120

Table 2.

Summary of variables to be collected during the study.

Study Variables
Primary:
Normalization of gut microbiota (after anti-TNF treatment) (yes/no)
Secondary variables:
A. Gut microbiota
  • -

    Initial dysbiosis (yes/no)

  • -

    Final dysbiosis (yes/no)

  • -

    Initial biodiversity level (low/medium/high)

  • -

    Final biodiversity level (low/medium/high)

  • -

    Increase in biodiversity (yes/no)

  • -

    Initial Faecalibacterium prausnitzii/Escherichia coli

  • -

    Final Faecalibacterium prausnitzii/Escherichia coli

  • -

    Initial Faecalibacterium prausnitzii/Clostridium coccoides group

  • -

    Final Faecalibacterium prausnitzii/Clostridium coccoides group

B. Clinical-biological parameters:
  • -

    Initial Harvey-Bradshaw Index

  • -

    Final Harvey-Bradshaw Index

  • -

    Initial C-reactive protein (mg/l)

  • -

    Final C-reactive protein (mg/l)

  • -

    Initial fecal calprotectin (µg/g)

  • -

    Final fecal calprotectin (µg/g)

C. Epidemiological data
  • -

    Age (years)

  • -

    Sex (male/female)

  • -

    Time from diagnosis to anti-TNF treatment (months)

  • -

    Body Mass Index (kg/m2)

  • -

    Smoking habit (yes/no)

  • -

    72-h dietary record

  • -

    Adherence to Mediterranean diet